pharmaphorum
OCTOBER 16, 2020
These might be licensed drugs that could hold potential for a patent extension, or drugs which failed efficacy trials for an intended indication. Findacure is a charity that works directly with rare disease patient groups to help them grow and professionalise.
Drug Discovery World
JANUARY 30, 2024
Dr Naldini open new doors for cures for otherwise untreatable genetic diseases with the full impact of his work still untapped”, she said. Intellectual property: High patent royalties and licensing fees for key technologies can inflate treatment costs. Fostering open innovation and collaboration could help address this issue.
Expert insights. Personalized for you.
105 
Let's personalize your content